Atommap
About Atommap
This company uses computational modeling of biomolecular motion to generate novel therapeutic designs, focusing on protein-protein interfaces for drug discovery. They employ generative models to create diverse molecular candidates, such as molecular glues and degraders, aligned with specific therapeutic hypotheses. Predictive computational assays accurately evaluate the binding affinity and functional potency of these designs, accelerating the identification of bioactive molecules.
This company uses computational modeling of biomolecular motion to generate novel therapeutic designs, focusing on protein-protein interfaces for drug discovery. They employ generative models to create diverse molecular candidates, such as molecular glues and degraders, aligned with specific therapeutic hypotheses. Predictive computational assays accurately evaluate the binding affinity and functional potency of these designs, accelerating the identification of bioactive molecules.
What does Atommap do?
This company uses computational modeling of biomolecular motion to generate novel therapeutic designs, focusing on protein-protein interfaces for drug discovery. They employ generative models to create diverse molecular candidates, such as molecular glues and degraders, aligned with specific therapeutic hypotheses. Predictive computational assays accurately evaluate the binding affinity and functional potency of these designs, accelerating the identification of bioactive molecules.
Where is Atommap located?
Atommap is based in City of New York, United States.
When was Atommap founded?
Atommap was founded in 2023.
How much funding has Atommap raised?
Atommap has raised $7.1M.
- Location
- City of New York, United States
- Founded
- 2023
- Funding
- $7.1M
- Employees
- 14 employees